Cover Image

A real-world study to assess the effectiveness of itolizumab in patients with chronic plaque psoriasis

Background: While clinical trial data on the efficacy of itolizumab in the management of psoriasis is relatively well documented, data on the effectiveness of this humanized IgG1 monoclonal antibody in real-world settings is sparse. Aims: The current study assessed the effectiveness of itolizumab in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anchala Parthasaradhi (Author), Vinay Singh (Author), S G Parasramani (Author), Nishi Yadav (Author), D S Krupashankar (Author), Manish Soni (Author), Rakesh Bansal (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Itolizumab in psoriasis
by: Ankita Srivastava
Published: (2017)

Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions
by: Vinay Singh
Published: (2016)

Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
by: Budamakuntla L, et al.
Published: (2019)

Itolizumab - A New Biologic for Management of Psoriasis and Psoriatic Arthritis
by: Ganesh Pai, et al.
Published: (2017)

Psoriasis management during the COVID-19 pandemic: Recommendations by SIG psoriasis (IADVL Academy)
by: Satyaki Ganguly, et al.
Published: (2021)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience
by: Abhishek De, et al.
Published: (2020)

Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis
by: Marloes E. van Muijen, et al.
Published: (2022)

Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
by: Menon R, et al.
Published: (2015)

Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis
by: Menon R, et al.
Published: (2015)

Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis
by: Tarja Mälkönen, et al.
Published: (2022)

Bimekizumab as treatment for moderate to severe chronic plaque psoriasis: Real world clinical experience from a district general hospital setting
by: Omowunmi Ashaolu, et al.
Published: (2024)

Real-world use of dimehtyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
by: Martina Burlando, et al.
Published: (2022)

Inflammasome Related Mediators and Their Association with Disease Determinants in Chronic Plaque Psoriasis
by: Seema Chhabra, et al.
Published: (2021)

Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience-IL PSO (Italian Landscape Psoriasis)
by: Diego Orsini, et al.
Published: (2024)

Congenital atrichia associated with nevus flammeus: A rare association
by: EP Raj Kirit, et al.
Published: (2014)

Follicular unit extraction technique in treating stable vitiligo with leukotrichia
by: Arragudla Vikram Kumar, et al.
Published: (2018)

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece
by: Dimitris Rigopoulos, et al.
Published: (2022)

Real-World Experience of Bimekizumab in an Elderly Patients Cohort with Plaque-Type Psoriasis: A 24-Week Retrospective Study
by: Fratton Z, et al.
Published: (2024)

Development of Dermatitis Herpetiformis in Chronic Plaque Psoriasis
by: Ruby Lee, et al.
Published: (2021)

Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
by: Tina Bhutani, et al.
Published: (2024)

Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
by: Alessio Gambardella, et al.
Published: (2023)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021)

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
by: April Armstrong, et al.
Published: (2024)

Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
by: Diego Orsini, et al.
Published: (2023)

Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania
by: Bucur S, et al.
Published: (2024)

Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic
by: Spyridon Gkalpakiotis, et al.
Published: (2023)

Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea
by: Byung Soo Kim, et al.
Published: (2024)

Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice
by: Yi-Teng Hung, et al.
Published: (2021)

Treatment outcomes of secukinumab in adult patients with moderate‐to‐severe plaque psoriasis in China: A real‐world multicenter retrospective study
by: Yangfeng Ding, et al.
Published: (2023)

Widespread superficial dermatophytosis in patient on secukinumab for treatment of chronic plaque psoriasis
by: Shekhar Neema, et al.
Published: (2019)

Eruptive vellus hair cyst
by: K Haritha, et al.
Published: (2016)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
by: Nicolazzo D, et al.
Published: (2014)

Central Pain Sensitization in Patients with Chronic Plaque Psoriasis
by: Francesco Bellinato, et al.
Published: (2023)

Stigma experienced by the caregivers of patients with chronic plaque psoriasis
by: Sandeep Grover, et al.
Published: (2021)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
by: Gisondi P, et al.
Published: (2016)

Real-world Methotrexate Use in a Prospective Cohort of Paediatric Patients with Plaque Psoriasis: Effectiveness, Adverse Events and Folic Acid Regimen
by: Finola M. Bruins, et al.
Published: (2022)

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
by: Emanuela Zagni, et al.
Published: (2021)

Dermoscopy to detect signs of subclinical nail involvement in chronic plaque psoriasis: A study of 68 patients
by: Tulika A Yadav, et al.
Published: (2015)

Interleukin levels and non-alcoholic fatty liver disease in chronic plaque psoriasis: An analytical case control study
by: Vidya Yadav, et al.
Published: (2023)

Management of Pustular Psoriasis; The Way Ahead
by: Shrichand G. Parasramani, et al.
Published: (2024)